Overview

Gemcitabine With Ascorbate Including Adolescents

Status:
Not yet recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see if a high dose of ascorbate (Vitamin C), in combination with the chemotherapy drug gemcitabine, is safe and effective in adolescents with locally advanced unresectable or metastatic soft tissue and bone sarcomas
Phase:
Early Phase 1
Details
Lead Sponsor:
William Terry
Treatments:
Gemcitabine